Regulatory Updates
Sep 17, 2026•1 min read
FDA Approves Lupin Pharmaceuticals' FYAVOLV (Norethindrone Acetate/Ethinyl Estradiol)
The FDA has approved ANDA204213 for FYAVOLV, a prescription oral tablet combining norethindrone acetate and ethinyl estradiol, manufactured by Lupin Pharmaceuticals.
Regulatory Updates
Sep 10, 2026•1 min read
FDA Approves ANDA 076335 for TRI-PREVIFEM Oral Tablet
The FDA approved ANDA 076335 for the oral tablet TRI-PREVIFEM, containing ethinyl estradiol and norgestimate, sponsored by PH HEALTH. The product is listed as discontinued.
Regulatory Updates
Sep 10, 2026•1 min read
FDA Approves ANDA077182 for Desogestrel/Ethinyl Estradiol Oral Tablets
The FDA has approved ANDA077182 submitted by Dr. Reddys Labs SA for prescription oral tablets containing desogestrel and ethinyl estradiol, including multiple dosage strengths.